GSK reaches $2.2bn Zantac settlement in US - Financial Times
- GSK reaches $2.2bn Zantac settlement in US Financial Times
- Thousands of cancer patients in line to share £1.7bn as GSK settles Zantac cases The Telegraph
- Statement: Zantac (ranitidine) litigation – settlement agreements reached GSK
- GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac The Guardian
- GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln Reuters